Fang Ying, Olah Mark E
Department of Pharmacology and Cell Biophysics, College of Medicine, University of Cincinnati, Ohio, USA.
J Pharmacol Exp Ther. 2007 Sep;322(3):1189-200. doi: 10.1124/jpet.107.119933. Epub 2007 Jun 12.
A critical process in angiogenesis is endothelial cell proliferation, which requires activation of extracellular signal-regulated kinase (ERK)1/2. This study analyzed the pathway responsible for adenosine-induced ERK1/2 phosphorylation in human umbilical vein endothelial cells (HUVEC). Characterization with adenosine receptor (AR) agonists and antagonists and the AR mRNA profile demonstrated that stimulation of the A(2B)AR can mediate ERK1/2 phosphorylation in HUVEC. The lack of sensitivity of A(2B)AR-mediated ERK1/2 phosphorylation to 3-[1-[3-(dimethylaminopropyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) and 3-[1-[3-(amidinothio)propyl]-1H-in-dol-3-yl]-3-(1-methyl-1H-indol-3-yl) maleimide (bisindolylmaleimide IX) (Ro31-8220) indicated that protein kinase C stimulation is not required. The response did not involve transactivation of receptors for epidermal growth factor or vascular endothelial growth factor (VEGF). The A(2B)AR-mediated response required functional G(alphas) and was mimicked by forskolin and 8-bromoadenosine 3',5'-cyclic monophosphate. However, ERK1/2 phosphorylation induced by A(2B)AR stimulation and forskolin was insensitive to protein kinase A inhibitors. It was hypothesized that the A(2B)AR-mediated ERK1/2 activation may involve exchange protein activated by cAMP (Epac), a cAMP-activated guanine nucleotide exchange factor for Rap GTPases. Reverse Transcription-polymerase chain reaction analysis detected Epac1 but not Epac2 in HUVEC. 8-(p-Chlorophenylthio)-2'-O-methyladenosine-3',5'-cyclic monophosphate (8CPT-2Me-cAMP), an Epac activator, stimulated ERK1/2 phosphorylation. Overexpression of Epac1 enhanced A(2B)AR-mediated and forskolin-induced ERK1/2 phosphorylation, whereas response to VEGF was unaffected. Inhibition of Epac1 expression with small interfering RNA substantially reduced A(2B)AR-mediated and forskolin-induced ERK1/2 phosphorylation and abolished that by 8CPT-2Me-cAMP. A(2B)AR stimulation and forskolin activated Rap1. Expression of a dominant-negative Ras protein did not affect either forskolin-induced or A(2B)AR-mediated ERK1/2 phosphorylation. In summary, Epac1 activation in HUVEC results in ERK1/2 activation, and this protein, at least in part, mediates response to the physiologically relevant event of A(2B)AR stimulation.
血管生成中的一个关键过程是内皮细胞增殖,这需要细胞外信号调节激酶(ERK)1/2的激活。本研究分析了人脐静脉内皮细胞(HUVEC)中腺苷诱导的ERK1/2磷酸化的相关信号通路。通过腺苷受体(AR)激动剂和拮抗剂以及AR mRNA谱的表征表明,A(2B)AR的刺激可介导HUVEC中ERK1/2的磷酸化。A(2B)AR介导的ERK1/2磷酸化对3-[1-[3-(二甲基氨基丙基]-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮单盐酸盐(GF109203X)和3-[1-[3-(脒硫基)丙基]-1H-吲哚-3-基]-3-(1-甲基-1H-吲哚-3-基)马来酰亚胺(双吲哚马来酰亚胺IX)(Ro31-8220)不敏感,这表明不需要蛋白激酶C的刺激。该反应不涉及表皮生长因子或血管内皮生长因子(VEGF)受体的反式激活。A(2B)AR介导的反应需要功能性G(alphas),并且可被毛喉素和8-溴腺苷3',5'-环磷酸酯模拟。然而,A(2B)AR刺激和毛喉素诱导的ERK1/2磷酸化对蛋白激酶A抑制剂不敏感。据推测,A(2B)AR介导的ERK1/2激活可能涉及cAMP激活的交换蛋白(Epac),一种Rap GTPases的cAMP激活的鸟嘌呤核苷酸交换因子。逆转录-聚合酶链反应分析在HUVEC中检测到Epac1但未检测到Epac2。8-(对氯苯硫基)-2'-O-甲基腺苷-3',5'-环磷酸酯(8CPT-2Me-cAMP),一种Epac激活剂,刺激ERK1/2磷酸化。Epac1的过表达增强了A(2B)AR介导的和毛喉素诱导的ERK1/2磷酸化,而对VEGF的反应不受影响。用小干扰RNA抑制Epac1表达可显著降低A(2B)AR介导的和毛喉素诱导的ERK1/2磷酸化,并消除8CPT-2Me-cAMP诱导的磷酸化。A(2B)AR刺激和毛喉素激活Rap1。显性负性Ras蛋白的表达对毛喉素诱导的或A(2B)AR介导的ERK1/2磷酸化均无影响。总之,HUVEC中Epac1的激活导致ERK1/2激活,并且该蛋白至少部分介导了对A(2B)AR刺激这一生理相关事件的反应。